We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Storage Cluster Software Supports Active and Archive Data for Genetic Research

By Biotechdaily staff writers
Posted on 07 Aug 2008
Cost-effective and scalable archive storage-cluster software has been developed for the growing volume of genotyping data for genetic researchers.

Caringo, Inc. More...
(Austin, TX, USA), a provider of content storage software that provides clustered storage infrastructure for storing both active and archive content, reported that its CAStor software was selected by the Center of Inherited Disease Research (CIDR) at Johns Hopkins University (Baltimore, MD, USA).

CIDR is a centralized facility providing genotyping and statistical genetics services for investigators seeking to identify genes that contribute to human disease. Through a U.S. grant, CIDR supports 13 U.S. National Institutes of Health (NIH; Bethesda, MD, USA) and mainly concentrates on multi-factorial hereditary disease as well as analysis of single gene disorders. Changes in the practice of genotyping over the past several years have led to a considerable increase in the amount of data generated and the need to implement something more manageable than the JBOD (just a bunch of drives) storage servers it was using.

CIDR currently has a 31-node CAStor cluster implemented with 104 TB of available capacity and 82 TB in use. Having an affordable, high-performance and scalable CAStor cluster helps meet CIDR's requirements in which it is producing 1 TB of new data each week and sometimes daily. It can generate as much as 2.5 TB of new data each day when operating at full capacity.

"The benefits of CAStor--affordability, scalability, and ease of management--are an unbeatable combination for organizations with massive amounts of critical data,” said Mark Goros, CEO, Caringo. "Johns Hopkins University's CIDR is a data-intensive environment with a need for dependable, fast archiving of clinical information, and CAStor's acceptance is a testament to its unique capabilities.”

CAStor is a scalable, high-performance, and cost-effective software product that runs on standard, commodity server hardware for a fraction of the price of other content-addressed storage (CAS) systems. CAStor is self-healing, managing, and configuring, uses no proprietary APIs (application programming interfaces), and requires no provisioning or downtime to add nodes and storage capacity in real time.

Caringo is a provider of content-storage software and it has reimagined content-addressed storage from the ground up with its flagship CAStor product. CAStor is third-generation technology that utilizes the customer's choice of commodity hardware for implementing a storage cluster that dramatically improves the scope and economics of corporate content storage.


Related Links:
Caringo
Johns Hopkins University

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.